检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:张晓姝[1] 赵海亚[1] 冯小英[1] 曹晏宁[1] 付爱丽[1] 薛江楠[1]
机构地区:[1]滨州医学院免疫学教研室,山东烟台264003
出 处:《基础医学与临床》2012年第3期261-267,共7页Basic and Clinical Medicine
基 金:国家自然科学基金(81001300);山东省自然科学基金(Y2007C009);山东省优秀中青年科学家科研奖励基金(2008BS03013)
摘 要:目的研究抑制性受体LAIR-1在巨核谱系细胞的表达及其对巨核细胞分化的调节作用。方法采用流式细胞术和激光共聚焦显微镜检测LAIR-1在巨核谱系细胞的表达;免疫磁珠法纯化脐血CD34+细胞,体外无血清培养系统诱导CD34+细胞向巨核细胞分化,观察LAIR-1被抗体或配体交联激活后对巨核细胞分化的影响。结果 LAIR-1表达于人骨髓CD34+CD41a+和CD41a+CD42b+细胞以及脐血CD34+CD41a-和CD34+CD41a+细胞;脐血CD34+细胞向巨核细胞分化过程中,LAIR-1表达在倍性为2N和4N的不成熟CD41a+细胞上;交联激活LAIR-1分子能够抑制脐血CD34+细胞向巨核细胞的分化。结论 LAIR-1可能是参与巨核细胞早期分化发育的一种新的负调控分子。Objective To study the expression of inhibitory receptor LAIR-1 on the megakaryocytic lineage cells and the regulatory effect of LAIR-1 on the differentiation of megakaryocytes(MKs).Methods Flow cytometry(FCM) and laser confocal microscopy were used to detect the expression of LAIR-1 on the megakaryocytic lineage cells.Cord blood CD34+ cells were purified by a positive selection using an immunomagnetic separation system.The CD34+ cells were induced to differentiate to MKs by serum-free medium system in vitro.LAIR-1 was activated by cross-linking with antibody or ligand and then the effect of LAIR-1 on the differentiation of MKs was detected.Results LAIR-1 was expressed on the surface of CD34+CD41a+ and CD41a+CD42b+ cells in the bone marrow of human.In human cord blood,the surface expression of LAIR-1 is detectable in CD34+CD41a-and CD34+CD41a+ cells.When cord blood CD34+ cells were induced to megakaryocytic differentiation,LAIR-1 presented in immature CD41a+ cells with cell ploidy of 2N and 4N.Cross-linking of LAIR-1 appeared to inhibit the differentiation of MKs from cord blood CD34+ cells.Conclusions LAIR-1 is a new potential negative regulatory molecule participating in the early-stage differentiation of MKs.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.200